FDA recall, , High risk
Baxter Cefazolin in Dextrose Injection
Cefazolin in Dextrose Injection may contain particulate matter, which can cause pulmonary emboli, blood vessel occlusions, and phlebitis.
Summary by Recall Canary from the FDA notice
What happened
Baxter Healthcare Corporation, of Deerfield, Illinois, voluntarily recalled Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, on July 24, 2026, due to the presence of particulate matter identified as cardboard in the solution. The product was distributed nationwide in the United States.
The recall, which began and was announced on July 24, 2026, was added to the FDA's Enforcement Report on August 13, 2026, and classified on August 21, 2026. The announcement stated that the use of the defective product has a risk.
3 photos
What to do
If a code on your package is listed below:
- Immediately discontinue use of and return all affected units in accordance with your facility’s process.
- Baxter is contacting customers with instructions on how to identify.
- Return the impacted product.
- For general questions regarding this communication, please contact Baxter Healthcare Center for Service at 888-229-0001 between the hours of 7:00 am and 6:00 pm Central Time, Monday through Friday.
Is yours affected?
Match the lot code, best-by or expiration date and NDC listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
2G3508
- NDC
- 0338-3508-41
- Lot code
- LD175708
- Best-by or expiration date
- 14-Feb-2027
Recall details
- Company began the recall
- Sold in
US Nationwide.
- Company
- Baxter Healthcare CorporationDeerfield, Illinois
- Hazard
- Foreign object
- Risk
High risk
There is a reasonable chance that taking it could cause serious health problems or death.
FDA Class I recall · How risk is rated
- Event ID
- 99463
- Recall number
- D-0787-2026
- Quantity recalled
- 19,032 bags
All recalls from Baxter Healthcare Corporation
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall · Announced by the company · Listed on Recall Canary
Added to FDA's Enforcement Report
In FDA's weekly enforcement report
Classified by FDA
Summary updated
